相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer
John R. Webb et al.
GYNECOLOGIC ONCOLOGY (2016)
PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
Junzo Hamanishi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2016)
Current status of immunotherapy
Susumu Suzuki et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2016)
Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma
Junichi Kiyasu et al.
BLOOD (2015)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Potential clinical application of interleukin-27 as an antitumor agent
Takayuki Yoshimoto et al.
CANCER SCIENCE (2015)
Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacy
Keishi Adachi et al.
CANCER SCIENCE (2015)
The Clinical Relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 Network in Chemoresistant Non-small-cell Lung Cancer
Yu Fujita et al.
MOLECULAR THERAPY (2015)
Role of tumor-associated macrophages in hematological malignancies
Yoshihiro Komohara et al.
PATHOLOGY INTERNATIONAL (2015)
Immune Checkpoint Protein Inhibition for Cancer: Preclinical Justification for CTLA-4 and PD-1 Blockade and New Combinations
Kathryn Baksh et al.
SEMINARS IN ONCOLOGY (2015)
Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study
Colm Keane et al.
LANCET HAEMATOLOGY (2015)
Immune cell promotion of metastasis
Takanori Kitamura et al.
NATURE REVIEWS IMMUNOLOGY (2015)
STAT1 Drives Tumor Progression in Serous Papillary Endometrial Cancer
Budiman Kharma et al.
CANCER RESEARCH (2014)
Clinical significance of macrophage heterogeneity in human malignant tumors
Yoshihiro Komohara et al.
CANCER SCIENCE (2014)
Inhibition of mitogen-activated protein kinase pathway can induce upregulation of human leukocyte antigen class I without PD-L1-upregulation in contrast to interferon-γ treatment
Kousaku Mimura et al.
CANCER SCIENCE (2014)
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Thomas Powles et al.
NATURE (2014)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
An optimized Protocol for Human M2 Macrophages using M-CSF and IL-4/IL-10/TGF-β Yields a Dominant Immunosuppressive Phenotype
S. Mia et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2014)
Gliomas Promote Immunosuppression through Induction of B7-H1 Expression in Tumor-Associated Macrophages
Orin Bloch et al.
CLINICAL CANCER RESEARCH (2013)
Modulation of inflammation by interleukin-27
Markus Bosmann et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
NF-κB Plays a Key Role in Inducing CD274 Expression in Human Monocytes after Lipopolysaccharide Treatment
Gang Huang et al.
PLOS ONE (2013)
IL-27 Production and STAT3-Dependent Upregulation of B7-H1 Mediate Immune Regulatory Functions of Liver Plasmacytoid Dendritic Cells
Benjamin M. Matta et al.
JOURNAL OF IMMUNOLOGY (2012)
The STATus of PD-L1 (B7-H1) on tolerogenic APCs
Tina L. Sumpter et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
PD-L1 expression on tolerogenic APCs is controlled by STAT-3
Sabine J. Woelfle et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer
Junzo Hamanishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy
A Sica et al.
EUROPEAN JOURNAL OF CANCER (2006)
Natural history of adult T-cell leukemia/lymphoma and approaches to therapy
GP Taylor et al.
ONCOGENE (2005)
B7-h1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression
J Konishi et al.
CLINICAL CANCER RESEARCH (2004)
PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells
P Loke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies
L Bingle et al.
JOURNAL OF PATHOLOGY (2002)
分享论文
